Description of the medicine: Ingacort
Synonyms: Flunisolide, Flunisolide, Fluxolonate.
Fluorine-containing glucocorticosteroid preparation for local (inhalation) therapy of bronchial asthma, as well as allergic rhinitis.
After inhalation (1 mg), bioavailability is 40% (undergoes biotransformation in the lungs), T Ѕ - 1.8 hours.
Adults and children from 6 to 14 years of age are prescribed 2 inhalations (0.5 mg) 2 times a day (morning and evening).
The maximum daily dose for adults should not exceed 8 inhalations (2 mg).
Improvement of lung function is usually observed 1-4 weeks after the start of treatment (the most complete effect is achieved after 4-6 weeks).
Possible side effects (oropharyngeal candidiasis, dysphonia, cough) occur less frequently than with beclomethasone.
Contraindications: infections of the oral cavity and bronchi, active tuberculosis, pregnancy and lactation.
Release form: the dosed aerosol in cans of 6 ml (0.25 mg / dose; 120 doses).